CASTEL SAN PIETRO, June 6, 2025 - Medacta Group SA ("Medacta," SIX:MOVE) is proud to announce its participation in the 15th Biennial International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine (ISAKOS) Congress, taking place in Munich, Germany, from June 8 to 11. Under the ISAKOS spotlight, Medacta unveils an expanded portfolio of sports medicine solutions following the acquisition of Parcus Medical in March 2025, all showcased at booth 03A. This milestone reflects the company's philosophy and commitment to advancing patient care and promoting healthcare sustainability through continuous investment in personalized and technology-enabled sports medicine solutions, designed to adapt to each patient’s unique anatomy and function. Surgeons can choose from an extensive range of specialized devices for the shoulder, elbow, hand & wrist, hip, knee, and foot & ankle procedures.
Among the expanded solutions is the X-Twist anchor platform and Draw Tight all-suture anchor fixation systems. “I’ve been using X-Twist for three years. It has consistently delivered the quality and reliability I expect in my practice. The instrumentation is easy to use and intuitive, and the fixation is robust. This anchor can be used both knotless and as a knotted traditional anchor, offering a wide spectrum of options for suture preference, including tape. The X-Twist can easily be used for nearly any soft tissue repair within the shoulder and throughout the body,” said Christopher E. Baker, M.D., from the Florida Orthopaedic Institute in Tampa, Florida.
This expanded portfolio establishes Medacta as a full-service partner for personalized soft tissue injury management and enhances its go-to-market strategy, supporting additional growth within the sports medicine business line. Furthermore, Medacta will be able to capitalize on opportunities due to its strong presence in the fast-growing US Ambulatory Surgical Centre (ASC) market.
“Our Sports Medicine portfolio is built on a foundation of deep anatomical insight, enabling us to design innovative, personalized repair and reconstructive solutions that closely replicate natural joint anatomy. This approach not only enhances joint function and biomechanics but also drives higher patient satisfaction with the aim to deliver clinically superior outcomes,” comments Francesco Siccardi, CEO of Medacta.
The proprietary and advanced MySolutions Personalized Ecosystem provides the technological foundation for further expanding the personalization capabilities of Medacta’s comprehensive sports medicine portfolio. Within this platform, MyPAO exemplifies how digital planning and 3D printing enable precise, patient-specific surgical execution during Periacetabular Osteotomy procedures.
All Medacta products are supported by the well renowned and tailored educational offerings provided by the M.O.R.E. Institute. With an international network of expert surgeons, the M.O.R.E. Institute is at the forefront of education with personalized, high-level educational pathways. With Medacta, the surgeon is never alone.
This milestone positions Medacta as a leading player in sports medicine innovation, delivering innovative and advanced solutions that drive sustainable improvement in patient care.
Discover more on the Medacta Sports Medicine website.
CONTACT
Gianluca Olgiati
Group Vice President Marketing
+41 91 696 60 60
ABOUT MEDACTA
Medacta is a global key player specializing in the design, production, and distribution of innovative, personalized, and sustainable solutions for joint replacement, sports medicine, and spine surgery. Established in 1999 in Switzerland, Medacta is committed to improving the care and well-being of patients and maintains a strong focus on healthcare sustainability. Through close collaboration with expert surgeons globally, continuous investments in R&D, and the adoption of cutting-edge technologies, Medacta’s innovation prioritizes minimally invasive surgery and personalized solutions for every patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 70 countries. Follow us on Medacta.com, Medacta TV, YouTube, LinkedIn and X.
Medacta Group SA acquires Parcus Medical to accelerate expansion in Sportsmed (March 7, 2025).
RELATED TRADEMARKS
Medacta Group Related Trademarks are registered at least in Switzerland. The products and services listed below may not be all-inclusive, and other Medacta products and services not listed below may be covered by one or more trademarks. The products and services listed below may be covered by additional trademarks not listed below. Note that Swiss trademarks may have foreign counterparts. MySolutions™ Personalized Ecosystem, MyPAO®.
